Leronlimab, CAS 674782-26-4

Product Description: Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Jiao X, et al. Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy. Breast Cancer Res. 2021 Jan 23;23(1):11.

CAS Number: 674782-26-4

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer; Infection

Solubility: 10 mM in DMSO

Target: CCR;HIV

• SKU: MEXHY-P99697-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99697-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated